221 related articles for article (PubMed ID: 33502788)
21. Hospital Prices For Commercial Plans Are Twice Those For Medicare Advantage Plans When Negotiated By The Same Insurer.
Meiselbach MK; Wang Y; Xu J; Bai G; Anderson GF
Health Aff (Millwood); 2023 Aug; 42(8):1110-1118. PubMed ID: 37549324
[TBL] [Abstract][Full Text] [Related]
22. The Secret Menu in Health Care: A Cash Market for Imaging in California.
Epstein J; Nicholson S; Wang LX; Hempstead K; Asin S
Inquiry; 2020; 57():46958020981449. PubMed ID: 33357108
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical policy in the Netherlands: from price regulation towards managed competition.
Boonen LH; van der Geest SA; Schut FT; Varkevisser M
Adv Health Econ Health Serv Res; 2010; 22():53-76. PubMed ID: 20575228
[TBL] [Abstract][Full Text] [Related]
24. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
Duijmelinck DM; Mosca I; van de Ven WP
Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
[TBL] [Abstract][Full Text] [Related]
25. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
Douven RC; Schut FT
J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
[TBL] [Abstract][Full Text] [Related]
26. Insurer-Provider Networks in the Medical Care Market.
Ho K
Am Econ Rev; 2009 Mar; 99(1):393-430. PubMed ID: 29504738
[TBL] [Abstract][Full Text] [Related]
27. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
[TBL] [Abstract][Full Text] [Related]
28. Is the medical loss ratio a good target measure for regulation in the individual market for health insurance?
Karaca-Mandic P; Abraham JM; Simon K
Health Econ; 2015 Jan; 24(1):55-74. PubMed ID: 24123608
[TBL] [Abstract][Full Text] [Related]
29. Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands.
Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
Health Policy; 2022 Feb; 126(2):122-128. PubMed ID: 35000802
[TBL] [Abstract][Full Text] [Related]
30. To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?
van der Hulst FJP; Holst L; Brabers AEM; de Jong JD
Health Policy; 2022 Jul; 126(7):693-703. PubMed ID: 35644719
[TBL] [Abstract][Full Text] [Related]
31. Managed care in four managed competition OECD health systems.
Shmueli A; Stam P; Wasem J; Trottmann M
Health Policy; 2015 Jul; 119(7):860-73. PubMed ID: 25776034
[TBL] [Abstract][Full Text] [Related]
32. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
Douven R; Katona K; T Schut F; Shestalova V
Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
[TBL] [Abstract][Full Text] [Related]
33. How does managed competition affect hospital prices in a social health insurance system? The Colombian case.
Fernando R; Leticia AB; Antonio J T
Health Policy Plan; 2018 Nov; 33(9):1037-1046. PubMed ID: 30462221
[TBL] [Abstract][Full Text] [Related]
34. Citizen engagement in healthcare procurement decision-making by healthcare insurers: recent experiences in the Netherlands.
Brito Fernandes Ó; Bos V; Klazinga N; Kringos D
Health Res Policy Syst; 2022 Dec; 20(1):137. PubMed ID: 36550520
[TBL] [Abstract][Full Text] [Related]
35. Assessing hospital competition when prices don't matter to patients: the use of time-elasticities.
Varkevisser M; van der Geest SA; Schut FT
Int J Health Care Finance Econ; 2010 Mar; 10(1):43-60. PubMed ID: 19662527
[TBL] [Abstract][Full Text] [Related]
36. Wide variation in hospital and physician payment rates evidence of provider market power.
Ginsburg PB
Res Brief; 2010 Nov; (16):1-11. PubMed ID: 21117341
[TBL] [Abstract][Full Text] [Related]
37. "Managed competition" for Ireland? The single versus multiple payer debate.
Mikkers M; Ryan P
BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
[TBL] [Abstract][Full Text] [Related]
38. Hospital and Health Insurance Markets Concentration and Inpatient Hospital Transaction Prices in the U.S. Health Care Market.
Dauda S
Health Serv Res; 2018 Apr; 53(2):1203-1226. PubMed ID: 28493481
[TBL] [Abstract][Full Text] [Related]
39. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
Bes RE; van den Berg B
Patient; 2013; 6(2):75-80. PubMed ID: 23549928
[TBL] [Abstract][Full Text] [Related]
40. The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer.
van der Hulst FJP; Brabers AEM; de Jong JD
BMC Health Serv Res; 2023 Jan; 23(1):52. PubMed ID: 36653840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
